Showing 41 - 60 results of 252 for search '"Регуляторные исследования и экспертиза лекарственных средств"', query time: 0.07s Refine Results
  1. 41

    Motor Routes to Support National Healthcare Objectives by article Editorial

    Published 2019-09-01
    “…Регуляторные исследования и экспертиза лекарственных средств…”
    Get full text
    Article
  2. 42

    ANALYSIS OF THE RESULTS OF USING AMINO, AMIDE AND NITRILE SORBENTS IN HYDROPHILIC INTERACTION LIQUID CHROMATOGRAPHY by A. S. Osipov, O. A. Popova, S. G. Larionova

    Published 2018-12-01
    “…Регуляторные исследования и экспертиза лекарственных средств…”
    Get full text
    Article
  3. 43

    Implementation of the drug samples tracing system by V. N. Kotikov, V. A. Petrosyants

    Published 2018-02-01
    “…Регуляторные исследования и экспертиза лекарственных средств…”
    Get full text
    Article
  4. 44

    RETRACTED: Opportunities of the method «Budget impact analysis» for performing pharmacoeconomic research by V. V. Ryazhenov, S. G. Gorokhova, N. D. Bunyatyan

    Published 2022-06-01
    “…Регуляторные исследования и экспертиза лекарственных средств…”
    Get full text
    Article
  5. 45

    Selection of Endpoints for Clinical Studies of Ophthalmic Drugs by M. O. Komarova

    Published 2021-10-01
    “…Регуляторные исследования и экспертиза лекарственных средств…”
    Get full text
    Article
  6. 46

    Organisation of the Work of Bioanalytical Laboratories according to the Principles of Good Clinical Laboratory Practice (Review) by I. S. Giba

    Published 2024-11-01
    “…Регуляторные исследования и экспертиза лекарственных средств…”
    Get full text
    Article
  7. 47

    Analysis of Biopharmaceutical Manufacturing Localisation in Russia Considering the Country of Origin of Active Pharmaceutical Ingredients by A. A. Khalimova, A. S. Orlov, A. A. Taube

    Published 2024-02-01
    “…Регуляторные исследования и экспертиза лекарственных средств…”
    Get full text
    Article
  8. 48

    Analysis of the Main Changes in Assessment and Approval of Medicines for Human Use in the Eurasian Economic Union by О. G. Nefidova, D. V. Babaskin, A. D. Sazonov, A. A. Kamaletdinova

    Published 2022-07-01
    “…Регуляторные исследования и экспертиза лекарственных средств…”
    Get full text
    Article
  9. 49

    V. V. Kosenko: “The National System of Expert Evaluation of Medicinal Products Should Be Modern” by O. F. Fedotova

    Published 2021-07-01
    “…Регуляторные исследования и экспертиза лекарственных средств…”
    Get full text
    Article
  10. 50

    Comparative study of perindopril and perindopril metabolite pharmacokinetics using the HPLC/MS method by L. M. Krasnykh, V. V. Smirnov, E. A. Egorenkov, G. F. Vasilenko, S. P. Dementyev, G. V. Ramenskaya

    Published 2018-02-01
    “…Регуляторные исследования и экспертиза лекарственных средств…”
    Get full text
    Article
  11. 51

    Prospects of using C3435T polymorphism in the <i>ABCB1</i> gene encoding P-glycoprotein in personalised medicine by R. E. Kazakov, V. A. Evteev, O. V. Muslimova, I. A. Mazerkina, E. Yu. Demchenkova, E. V. Shikh

    Published 2018-02-01
    “…Регуляторные исследования и экспертиза лекарственных средств…”
    Get full text
    Article
  12. 52

    INFORMATION SYSTEM FOR EXPERT EVALUATION OF MEDICINES INTERCHANGEABILITY by D. P. Andreev, E. M. Rychikhina, A. V. Kozlovich, B. K. Romanov

    Published 2018-06-01
    “…Регуляторные исследования и экспертиза лекарственных средств…”
    Get full text
    Article
  13. 53

    Recommendations for the Content of a Product Specification File: Water (Karl Fischer Method) by O. A. Vaganova, A. A. Natykan

    Published 2024-07-01
    “…Регуляторные исследования и экспертиза лекарственных средств…”
    Get full text
    Article
  14. 54

    Criteria for evaluation of clinical efficacy of anticancer medicines by A. V. Tikhomirova

    Published 2019-03-01
    “…Регуляторные исследования и экспертиза лекарственных средств…”
    Get full text
    Article
  15. 55

    <sup>18</sup>F-FDG PET/CT in the Diagnosis of Cervical Cancer by A. V. Leontyev, M. M. Khodzhibekova, A. I. Khalimon, M. T. Kuliev, G. F. Khamadeeva, T. L. Antonevskaya, T. N. Lazutina, A. D. Kaprin

    Published 2022-12-01
    “…Регуляторные исследования и экспертиза лекарственных средств…”
    Get full text
    Article
  16. 56

    The Problem of Dynamic Process Manifestation in Identification of Organic Compounds by NMR Spectroscopy by N. E. Kuz’mina, S. V. Moiseev, A. I Luttseva

    Published 2020-02-01
    “…Регуляторные исследования и экспертиза лекарственных средств…”
    Get full text
    Article
  17. 57

    Concept formulation for «automated expert workplace» by V. N. Kotikov, V. A. Petrosyants

    Published 2018-02-01
    “…Регуляторные исследования и экспертиза лекарственных средств…”
    Get full text
    Article
  18. 58

    Planning a Clinical Development Programme for Medicinal Products for Irritable Bowel Syndrome: An Analysis of the European Medicines Agency’s Recommendations by E. A. Gerasimets, N. A. Rumyantsev, R. S. Ilin, D. V. Goryachev

    Published 2024-09-01
    “…Регуляторные исследования и экспертиза лекарственных средств…”
    Get full text
    Article
  19. 59

    The system of secondary reference standards in drug quality control laboratories by D. A. Leontiev

    Published 2018-02-01
    “…Регуляторные исследования и экспертиза лекарственных средств…”
    Get full text
    Article
  20. 60

    Improvement of Microbiological Methods for Testing the Quality of Non-sterile Medicines with Antimicrobial Effects by O. V. Gunar, G. M. Bulgakova

    Published 2024-07-01
    “…Регуляторные исследования и экспертиза лекарственных средств…”
    Get full text
    Article